Dokter Kanker kandung kemih di Luar Negeri — Halaman 3

Associated Professor Dr. Yusuf Acikgoz membawa pengalaman onkologi internasional dari Ohio State University ke Rumah Sakit Universitas Lokman Hekim Ankara.

• Spesialisasi dalam Onkologi Medis dengan fokus pada kanker kandung kemih
• Berpartisipasi dalam uji klinis Fase III seperti CheckMate-649 dan Fortitude-101
• Tersertifikasi dalam Praktik Klinis yang Baik dan Perlindungan Subjek Manusia
• Anggota dari American Society of Clinical Oncology (ASCO)

Dr. Elkhan Mammadov is a medical oncologist. He focuses on cancer diagnosis and treatment, including cytotoxic chemotherapy, hormone therapy, targeted therapy (smart drugs), and immunotherapy.

Education: Azerbaijan Medical University, MD (2004–2010). Istanbul University, Istanbul Faculty of Medicine, Internal Medicine training (2014–2019). Istanbul Medipol Mega University Hospital, Medical Oncology subspecialty training (2019–2022).

Experience: 5 years in Internal Medicine. 3 years in Medical Oncology.

Memberships: Turkish Society for Medical Oncology. ESMO (European Society for Medical Oncology). ASCO (American Society of Clinical Oncology).

Prof. Köstler berspesialisasi dalam terapi bertarget untuk kanker kandung kemih, dengan penelitian ekstensif dalam onkologi presisi di Wiener Privatklinik.

• Pengalaman lebih dari 20 tahun di bidang onkologi medis
• Fokus pada pengembangan biomarker dan imunoterapi
• Associate Professor di Universitas Kedokteran Wina
• Dipublikasikan di jurnal onkologi internasional terkemuka

Dr. Hughes Hyun berspesialisasi dalam bedah robotik dan invasif minimal untuk kanker kandung kemih di Sourasky Medical Center.

• Ahli bedah bersertifikat dengan pengalaman luas
• Berfokus pada teknik robotik tingkat lanjut
• Praktik di salah satu pusat medis terkemuka di Israel

Pakar dalam pengobatan kanker kandung kemih dengan fokus pada diagnostik molekuler dan imunoterapi. Phd Viola Fox memimpin Klinik Hematologi, Onkologi, dan Perawatan Paliatif di BKZ Solingen.

• Spesialisasi dalam kemoterapi, imunoterapi, dan terapi target
• Anggota aktif American Association for Cancer Research
• Spesialis berkualifikasi di bidang genetika sejak 2016
• Wakil Kepala Dokter di Klinik Pulmonologi Köln sejak 2011

Associate Professor Tahsin Ozatli berspesialisasi dalam kanker payudara, paru-paru, dan gastrointestinal, merawat pasien di Rumah Sakit Liv Universitas Istinye Bahcesehir.

• Terlatih dalam kedokteran internal di Rumah Sakit Negara Malatya
• Bekerja di Klinik Onkologi Ankara dengan fokus pada onkologi
• Anggota departemen onkologi di Rumah Sakit Pelatihan dan Penelitian Regional Erzurum
• Profesor madya sejak 2016

Profesor Sebastian Keil memimpin Klinik Radiologi Diagnostik dan Intervensi di Solingen, dengan spesialisasi dalam teknik pencitraan tingkat lanjut.

• Lulus dengan pujian dari Julius-Maximilians-Universität Würzburg
• Ahli dalam MRI, CT, dan ultrasonografi untuk intervensi kompleks
• Mantan dokter terkemuka di bawah bimbingan Profesor ternama Christian K. Kuhl
• Menyediakan berbagai layanan radiologi intervensi secara lengkap

Spesialisasi dalam viroterapi – bidang mutakhir dalam imunologi – Dr. Inta Jaunalksne membawa 30+ tahun pengalaman dalam pengobatan kanker kandung kemih di Pallas Clinic.

• Kepala Pusat Imunologi Klinis di Rumah Sakit Universitas Klinis Pauls Stradins
• Lulusan Institut Medis Riga dengan magang di Penyakit Dalam
• Berfokus pada pendekatan imunologi inovatif untuk pengobatan kanker

Profesor Cemil Bilir spesialis dalam kanker kandung kemih dengan pelatihan ekstensif di lembaga bergengsi seperti Cleveland Clinic dan Northeastern University.

• Sertifikasi dewan dalam onkologi medis dengan pengalaman lebih dari 15 tahun
• Anggota ASCO dan ESMO – mengikuti pedoman pengobatan internasional
• Melakukan penelitian dalam bioteknologi farmasi untuk terapi tingkat lanjut
• Profesor di Universitas Sakarya – melatih calon onkolog masa depan

Dr. Ozden berspesialisasi dalam pengobatan kanker kandung kemih dengan pelatihan ekstensif di bidang onkologi medis di Fakultas Kedokteran Universitas Kocaeli.

• Pengalaman lebih dari 20 tahun di bidang penyakit dalam dan onkologi
• Menempuh pendidikan di Universitas Istanbul, salah satu sekolah kedokteran ternama di Turki
• Ahli dalam protokol kemoterapi dan imunoterapi untuk kanker kandung kemih

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

• Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
• Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
• Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
• Treats complex oncological cases at the university-affiliated İstinye University clinic.

Dr. Mariam Abu Zeid is a clinical oncologist at Shefaa Al Orman International Oncology Hospitals. She is certified by the European Society for Medical Oncology. Dr. Abu Zeid treats solid tumors and hematologic cancers. She holds a Ph.D. in Clinical Oncology and Nuclear Medicine from Ain Shams University.

• Administers chemotherapy, immunotherapy, and targeted treatments for various cancer types.
• Oversees oncology clinical trials and manages treatment-related toxicities.
• Coordinates patient care within multidisciplinary teams for complex staging and diagnosis.
• Practices at an ESMO-accredited center that treats approximately 6,000 patients annually.

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Professor Zheng Qiu Hong is Director of the Cell Therapy Research Center and a National Senior Expert in Biotherapy. He is a Professor and Master’s Supervisor at Fujian Medical University. He has more than 30 years of clinical experience in tumor molecular biology and biotherapy. From 2012 to 2013, he was a visiting scholar in stem cell research at the University of Connecticut School of Life Sciences. He previously held leadership roles at Fujian Cancer Hospital. These roles included Director of the Tumor Molecular Biology Laboratory and Director of the Surgical Oncology Research Laboratory. He also served as Deputy Director of the Fujian Key Laboratory of Tumor Biotherapy and Deputy Director of the Biotherapy and Immunotherapy Center.

Appointments include Standing Committee Member of the Biotherapy Committee of the Chinese Research Hospital Association. He is also a Committee Member of the Tumor Immunology and Biotherapy Committee of the Chinese Society for Immunology. In addition, he is Deputy Chair of the Academic Committee of the Xiamen Cell Therapy Research Center at the First Affiliated Hospital of Xiamen University.

Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.

• Highly proficient in IMRT, VMAT, and SBRT for lung and esophageal cancers.
• Former President of Jilin Provincial Cancer Hospital.
• Awarded the National Famous Doctor honor for outstanding contributions to oncology.
• Holds leadership roles in the Chinese Anti-Cancer Association particle therapy committee.

Urologist, Surgeon

Dr. Zohar Dotan heads the Urology Department at Sheba Medical Center in Israel. He is a primary pioneer of robotic and laparoscopic urologic surgery. He specializes in treating complex cancers of the kidney, prostate, and bladder. Dr. Dotan leads the Israeli Uro-Oncology Society and holds a PhD in Genetics.

• Completed a specialized uro-oncology fellowship at Memorial Sloan Kettering in New York.
• Performs robotic radical nephrectomy and da Vinci robotic prostatectomy.
• Authored over 50 scientific publications on advanced urologic cancer treatments.
• Works at Sheba Medical Center, ranked 7th best hospital globally by Newsweek.

Dr. Emad Shash is a medical oncologist who has participated in over 70 oncology clinical trials. He serves as the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. Dr. Shash specializes in systemic therapies, including chemotherapy, targeted therapy, and immunotherapy. He holds a Diploma in Hospital Quality Management and Patient Safety from JCI.

• Serves as an ESMO panel voting member and an ASCO committee member.
• Treats breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers.
• Former research physician and medical lead at the EORTC in Brussels.
• Works at Shefaa Al Orman, an ESMO-accredited oncology center treating 6,000 patients annually.

Dr. Amiel adalah Kepala Departemen Urologi di Rambam Medical Center, yang berfokus pada bedah kanker. Perannya menunjukkan keahlian mendalam dalam kasus-kasus urologi yang kompleks.

• Spesialisasi sebagai ahli bedah onkologi untuk kanker sistem urin
• Memberikan perawatan di rumah sakit universitas besar di Israel